Naviscan's Asset Sale

Naviscan raised a round of funding on December 11, 2013. Investors include Compania Mexicana de Radiologia.

Naviscan has developed a breast cancer product which utilizes PET (Positron Emission Tomography) technologies.…

Articles about Naviscan's Asset Sale: